Visualization Score of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging: The Effect on the Diagnostic Accuracy for Hepatocellular Carcinoma

被引:5
作者
Heo, Subin [1 ,2 ,3 ]
Choi, Sang Hyun [1 ,2 ]
Hong, Sun [1 ,2 ]
Kim, Dong Wook [1 ,2 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Univ Ulsan, Asan Med Ctr, Coll Med, Res Inst Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[3] Ajou Univ, Dept Radiol, Sch Med, Suwon, South Korea
关键词
liver; gadolinium ethoxybenzyl DTPA; hepatocellular carcinoma; diagnosis; GD-EOB-DTPA; HEPATOBILIARY PHASE; LIVER-FUNCTION; MRI; HCC; CT;
D O I
10.1002/jmri.28357
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background The visualization score of hepatobiliary-phase (HBP) images has been introduced as an image quality index for gadoxetic acid-enhanced MRI. It may be associated with hepatic function and could have an implication on the diagnostic accuracy for hepatocellular carcinoma (HCC). Purpose To investigate the association between the visualization score of gadoxetic acid-enhanced MRI and clinical factors and to evaluate its effect on the diagnostic accuracy for HCC <= 3.0 cm. Study type Retrospective. Population A total of 493 focal lesions from 397 patients. Field strength/Sequence A 5-T or 3.0 -T with pre/postcontrast T1-weighted 3D gradient echo sequence, and T2-weighted fast spin-echo sequence Assessment Child-Pugh classification and albumin-bilirubin (ALBI) score were assessed. Three readers evaluated the visualization score of each MRI examination (A, no or minimal; B, moderate; and C, severe limitations), and major features (arterial-phase hyperenhancement, washout, enhancing capsule, threshold growth) and ancillary features of each focal lesion. Statistical Tests Univariable and multivariable logistic regression analyses were performed to determine significant clinical factors associated with a suboptimal visualization score (B or C). Generalized estimating equations were used to compare the sensitivity and specificity for diagnosing HCC between the two group (visualization score A vs. B or C). A P value < 0.05 was considered statistically significant. Results Of the 397 MRI examinations, the incidence of suboptimal visualization score was 13%. A suboptimal visualization score was significantly associated with Child-Pugh classification B or C (adjusted odds ratio [OR] = 15.2) and ALBI grade 2 or 3 (OR = 4.7). Compared with the visualization score A group, the suboptimal visualization score group showed significantly lower sensitivity (56.8% vs. 75.2%) and less frequent washout in HCC (62.2% vs. 84.0%). Data Conclusion The visualization score on gadoxetic acid-enhanced MRI can be an important image quality index and the diagnostic accuracy for HCC <= 3.0 cm may not be sufficient in the suboptimal visualization score group. Level of Evidence 3 Technical Efficacy Stage 3
引用
收藏
页码:941 / 949
页数:9
相关论文
共 27 条
[1]   Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance [J].
An, Julie Y. ;
Pena, Miguel A. ;
Cunha, Guilherme M. ;
Booker, Michael T. ;
Taouli, Bachir ;
Yokoo, Takeshi ;
Sirlin, Claude B. ;
Fowler, Kathryn J. .
RADIOGRAPHICS, 2020, 40 (07) :1916-1931
[2]   EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice [J].
Aube, Christophe ;
Oberti, Frederic ;
Lonjon, Julie ;
Pageaux, Georges ;
Seror, Olivier ;
N'Kontchou, Gisele ;
Rode, Agnes ;
Radenne, Sylvie ;
Cassinotto, Christophe ;
Vergniol, Julien ;
Bricault, Ivan ;
Leroy, Vincent ;
Ronot, Maxime ;
Castera, Laurent ;
Michalak, Sophie ;
Esvan, Maxime ;
Vilgrain, Valerie .
LIVER INTERNATIONAL, 2017, 37 (10) :1515-1525
[3]   Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters [J].
Bastati, Nina ;
Wibmer, Andreas ;
Tamandl, Dietmar ;
Einspieler, Henrik ;
Hodge, Jacqueline C. ;
Poetter-Lang, Sarah ;
Rockenschaub, Susanne ;
Berlakovich, Gabriela A. ;
Trauner, Michael ;
Herold, Christian ;
Ba-Ssalamah, Ahmed .
INVESTIGATIVE RADIOLOGY, 2016, 51 (11) :728-734
[4]   Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients [J].
Chernyak, Victoria ;
Fowler, Kathryn J. ;
Kamaya, Aya ;
Kielar, Ania Z. ;
Elsayes, Khaled M. ;
Bashir, Mustafa R. ;
Kono, Yuko ;
Do, Richard K. ;
Mitchell, Donald G. ;
Singal, Amit G. ;
Tang, An ;
Sirlin, Claude B. .
RADIOLOGY, 2018, 289 (03) :816-830
[5]  
Child C G, 1964, Major Probl Clin Surg, V1, P1
[6]   Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging [J].
Cui, Enming ;
Long, Wansheng ;
Luo, Liangping ;
Hu, Maoqing ;
Huang, Liebin ;
Chen, Xiangmeng .
ACTA RADIOLOGICA, 2017, 58 (10) :1174-1181
[7]   Intraindividual Comparison of Gadoxetate Disodium-enhanced MR Imaging and 64-Section Multidetector CT in the Detection of Hepatocellular Carcinoma in Patients with Cirrhosis [J].
Di Martino, Michele ;
Marin, Daniele ;
Guerrisi, Antonino ;
Baski, Mahbubeh ;
Galati, Francesca ;
Rossi, Massimo ;
Brozzetti, Stefania ;
Masciangelo, Raffaele ;
Passariello, Roberto ;
Catalano, Carlo .
RADIOLOGY, 2010, 256 (03) :806-816
[8]   EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 69, pg 182, 2018) [J].
Galle, Peter R. ;
Forner, Alejandro ;
Llovet, Josep M. ;
Mazzaferro, Vincenzo ;
Piscaglia, Fabio ;
Raoul, Jean-Luc ;
Schirmacher, Peter ;
Vilgrain, Valerie .
JOURNAL OF HEPATOLOGY, 2019, 70 (04) :817-817
[9]   Enhancement of Liver Parenchyma After Injection of Hepatocyte-Specific MRI Contrast Media: A Comparison of Gadoxetic Acid and Gadobenate Dimeglumine [J].
Filippone, Antonella ;
Blakeborough, Anthony ;
Breuer, Josy ;
Grazioli, Luigi ;
Gschwend, Simone ;
Hammerstingl, Renate ;
Heinz-Peer, Gertraud ;
Kittner, Thomas ;
Laghi, Andrea ;
Leen, Edward ;
Lencioni, Riccardo ;
Lucidarme, Olivier ;
Remplik, Philipp ;
Robinson, Philip J. ;
Ruehm, Stefan G. ;
Schaefer, Fritz ;
Stoupis, Christoforos ;
Tombach, Bernd ;
Valette, Pierre-Jean ;
Zech, Christoph J. ;
Huppertz, Alexander .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2010, 31 (02) :356-364
[10]   PHASE-I CLINICAL-EVALUATION OF GD-EOB-DTPA AS A HEPATOBILIARY MR CONTRAST AGENT - SAFETY, PHARMACOKINETICS, AND MR-IMAGING [J].
HAMM, B ;
STAKS, T ;
MUHLER, A ;
BOLLOW, M ;
TAUPITZ, M ;
FRENZEL, T ;
WOLF, KJ ;
WEINMANN, HJ ;
LANGE, L .
RADIOLOGY, 1995, 195 (03) :785-792